Malin Corporation plc is a biotechnology company founded in 2014 that invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders. The company is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. Malin's purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential. The company's last investment was a €50.00M Venture Round investment on 01 March 2015, with the Ireland Strategic Investment Fund being the investor. With a focus on supporting companies in the life sciences sector, Malin Corporation plc aims to leverage its capital and strategic resources to drive value creation and innovation in the biotechnology industry. For more information, visit www.malinplc.com or connect with them on Twitter @Malin_plc to stay updated on their latest developments and investments.
No recent news or press coverage available for Malin Corporation plc.